Log In
Friday 20th April 2018

Alzheimer's drug decision reversed

24th March 2011

The National Institute for Health and Clinical Excellence (NICE) has extended the use of three drugs to treat Alzheimer’s disease.

Aricept, exelon and reminyl are currently available through the NHS to sufferers of the condition who have moderate to severe symptoms but the drugs, which costs around £2.80 per patient per day, has now been approved for patients with milder problems. A fourth drug - ebixa - will be extended to people suffering more moderate symptoms after only previously being given to those in the late stages of the disease.


Share this page


There are no comments for this article, be the first to comment!

Post your comment

Only registered users can comment. Fill in your e-mail address for quick registration.

Your email address:

Your comment will be checked by a Healthcare Today moderator before it is published on the site.

Article Information

Title: Alzheimer's drug decision reversed
Author: Mark Nicholls
Article Id: 17994
Date Added: 24th Mar 2011


Nursing Times

Recent Related Articles

Prescription drug addiction to be reviewed

Teachers diagnosed with mental health issues


Add to scrapbook
Show Comments
Add comment
Find all related articles


M3 - For secure managed hosting over N3 or internet
© Mayden Foundation 2018